Diabetic Retinopathy Prevalence in High Income and Low Middle-Income Countries
Associate Professor of Ophthalmology (NAMS), Vitreo-retina specialist, Tilganga Institute of Ophthalmology, Kathmandu, Nepal
*Corresponding Author: Raba Thapa, Associate Professor of Ophthalmology (NAMS), Vitreo-retina specialist, Tilganga Institute of Ophthalmology, Kathmandu, Nepal.
May 23, 2021; Published: August 18, 2021
Diabetes Mellitus (DM) is emerging as a major public health problem globally. DM has been the leading cause of mortality and various morbidities including blindness both in high income and in low and middle-income countries. In recent report of International Diabetes Federation (IDF), 463 million adults aged 20 - 79 years worldwide (9.3% of all adults in this age group) have diabetes in 2019 and this number is projected to be 478 million by 2030 and 700 million by 2045 globally . Almost four fifth (79.4%) of people with diabetes live in low and middle-income countries. The burden of diabetes has overwhelmed many healthcare systems, especially those of low and middle-income countries .
- International Diabetes Federation. Diabetes Atlas”. 9th Brussels: IDF (2019).
- World Health Organization. “Prevention of blindness from diabetes mellitus: report of a WHO consultation in Geneva”. Geneva: World Health Organization (2006).
- Leasher JL., et al. “Vision Loss Expert Group of the global burden of disease study. Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A Meta-analysis from 1990 to 2010”. Diabetes Care9 (2016): 1643-1649.
- Shaw JE., et al. “Global estimates of the prevalence of diabetes for 2010 and 2030”. Diabetes Research and Clinical Practice1 (2010): 4-14.
- Yau JW., et al. “Meta-analysis for eye disease (META-EYE) study group. Global prevalence and major risk factors of diabetic retinopathy”. Diabetes Care3 (2012): 556-564.
- Lee R., et al. “Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss”. Eye Vis1 (2015): 17.
- Wong TY and Sabanayagama C. “Strategies to Tackle the Global Burden of Diabetic Retinopathy: From epidemiology to artificial intelligence”. Ophthalmologica 243 (2020): 9-20.
- Takkar B., et al. “Development of Diabetic retinopathy screening guidelines in South-East Asia region using the context, challenges, and future technology”. Seminars in Ophthalmology (2021): 1-8.
- Thapa R., et al. “Prevalence and risk factors of diabetic retinopathy among an elderly population with diabetes in Nepal: The Bhaktapur Retina Study”. Clinical Ophthalmology 12 (2018): 561-568.
- Mishra SK., et al. “The prevalence of diabetic retinopathy among known diabetic population in Nepal”. Kathmandu University Medical Journal2 (2016): 134-139.
- Paudyal G., et al. “Prevalence of diabetic retinopathy following a community screening for diabetes”. Nepal Medical College Journal 3 (2008): 160-163.
- Shrestha MK., et al. “Prevalence of and factors associated with diabetic retinopathy among diabetics in Nepal: a hospital based study”. Nepal medical College Journal 4 (2007): 225-229.
- Thapa R., et al. “Prevalence, risk factors and awareness of diabetic retinopathy among admitted diabetic patients at a tertiary level hospital in Kathmandu”. Nepalese Journal of Ophthalmology 11 (2014): 24-30.
- Shrestha S., et al. “Retinopathy in a diabetic population”. Kathmandu University Medical Journal 2 (2007): 204-209.
- Raymond NT., et al. “UK Asian Diabetes Study Retinopathy Study Group. Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study”. Diabetes Care 3 (2009): 410-415.
- Tan GS., et al. “Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study”. Ophthalmology4 (2018): 529-536.
- Zhang X., et al. “Prevalence of diabetic retinopathy in the United States, 2005- 2008”. JAMA: The Journal of the American Medical Association6 (2010): 649-656.
- Klein R., et al. “The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more”. Archives of Ophthalmology2 (1989): 244-249.
- Klein R., et al. “The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years”. Archives of Ophthalmology2 (1989): 237-243.
- Ruta LM., et al. “Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries”. Diabetic Medicine 30 (2013): 387-398.
- Thomas RL., et al. “IDF Diabetes Atlas: A review of studies utilizing retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018”. Diabetes Research and Clinical Practice (2019): 157.